The Company That Makes Remdesivir Says it Considerably Reduces COVID-19 Deaths
In a study, those getting remdesivir showed a 62% lower risk of mortality
Related Articles
How COVID-19 Affects the Brain, Even Long After an Infection
It’s been linked to brain fog, dementia, stroke, and more.
Now We Need to Worry About Harmful ‘Forever Chemicals’ in Our Toilet Paper Too
A new global study finds harmful PFAS chemicals in toilet paper and sewage
The Scientist At the Heart of COVID Lab Leak Conspiracies
Ralph Baric could help save humanity from the next pandemic—if his enemies don’t get him first.
The Scientist At the Heart of COVID Lab Leak Conspiracies
Ralph Baric could help save humanity from the next pandemic—if his enemies don’t get him first.
Why Do We Dream? A New Theory on How It Protects Our Brains
“Dreams are primarily visual precisely because this is the only sense that is disadvantaged by darkness.”
Why Americans Are Dying So Young
One in 25 American five-year olds will not reach their 40th birthday
Robert F Kennedy Jr. Is Dead Wrong About Vaccines
There is no point in debating RFK Jr. on vaccines. He’s wrong and has been proven so many times before
Study: Melanoma Survival Rates Vary Dramatically By Race
Black men are less likely to be diagnosed with skin cancer, but more likely to die from it
Exclusive: The $2 Per Hour Workers Who Made ChatGPT Safer
A TIME investigation reveals the difficult conditions faced by the workers who made ChatGPT possible
